ClinicalTrials.gov record
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov ID: NCT01216072
Public ClinicalTrials.gov record NCT01216072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-month, Randomized, Active Comparator, Open-label, Multi-Center Study to Evaluate Patient OutComes, Safety and Tolerability of Fingolimod (FTY720) 0.5 mg/Day in Patients With Relapsing Forms of Multiple Sclerosis Who Are Candidates for MS Therapy Change From Previous Disease Modifying Therapy (EPOC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the change in patient-reported outcomes, physician assessment of a change as well as safety and tolerability in patients with Relapsing Forms of Multiple Sclerosis on previous Disease Modifying Therapy (DMT) who are randomized to one of two treatment arms: fingolimod vs. standard of care DMT.
Study identification
- NCT ID
- NCT01216072
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,053 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2010 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Feb 10, 2014
2010 – 2012
United States locations
- U.S. sites
- 142
- U.S. states
- 34
- U.S. cities
- 128
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35209 | — |
| Novartis Investigative Site | Cullman | Alabama | 35058 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85004 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85006 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85013 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85032 | — |
| Novartis Investigative Site | Tucson | Arizona | 85741 | — |
| Novartis Investigative Site | Anaheim | California | 92801 | — |
| Novartis Investigative Site | Berkeley | California | 94705 | — |
| Novartis Investigative Site | Fresno | California | 93710 | — |
| Novartis Investigative Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | La Habra | California | 90631 | — |
| Novartis Investigative Site | Loma Linda | California | 92354 | — |
| Novartis Investigative Site | Newport Beach | California | 92660 | — |
| Novartis Investigative Site | Oceanside | California | 92056 | — |
| Novartis Investigative Site | Sacramento | California | 95817 | — |
| Novartis Investigative Site | Walnut Creek | California | 94598 | — |
| Novartis Investigative Site | Boulder | Colorado | 80304 | — |
| Novartis Investigative Site | Colorado Springs | Colorado | 80920 | — |
| Novartis Investigative Site | Fort Collins | Colorado | 80528 | — |
| Novartis Investigative Site | Fairfield | Connecticut | 06824 | — |
| Novartis Investigative Site | New London | Connecticut | 06320 | — |
| Novartis Investigative Site | Stratford | Connecticut | 06615 | — |
| Novartis Investigative Site | Dover | Delaware | 19901 | — |
| Novartis Investigative Site | Newark | Delaware | 19713 | — |
| Novartis Investigative Site | Atlantis | Florida | 33462-6608 | — |
| Novartis Investigative Site | Bradenton | Florida | 32405 | — |
| Novartis Investigative Site | Doral | Florida | 33166 | — |
| Novartis Investigative Site | Fort Lauderdale | Florida | 33308 | — |
| Novartis Investigative Site | Hollywood | Florida | 33021 | — |
| Novartis Investigative Site | Jacksonville | Florida | 32209 | — |
| Novartis Investigative Site | Jacksonville | Florida | 32216 | — |
| Novartis Investigative Site | Lighthouse PT | Florida | 33064 | — |
| Novartis Investigative Site | Maitland | Florida | 32751 | — |
| Novartis Investigative Site | Miami | Florida | 33015 | — |
| Novartis Investigative Site | Miami | Florida | 33133 | — |
| Novartis Investigative Site | Pompano Beach | Florida | 33060 | — |
| Novartis Investigative Site | Ponte Vedra Beach | Florida | 32082-4627 | — |
| Novartis Investigative Site | Port Orange | Florida | 32127 | — |
| Novartis Investigative Site | Sarasota | Florida | 34243 | — |
| Novartis Investigative Site | St. Petersburg | Florida | 33713 | — |
| Novartis Investigative Site | Sunrise | Florida | 33351 | — |
| Novartis Investigative Site | Tallahassee | Florida | 32308 | — |
| Novartis Investigative Site | Tampa | Florida | 33609 | — |
| Novartis Investigative Site | Tampa | Florida | 33612 | — |
| Novartis Investigative Site | Vero Beach | Florida | 32960 | — |
| Novartis Investigative Site | West Palm Beach | Florida | 33407 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30302 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30309 | — |
| Novartis Investigative Site | Columbus | Georgia | 31901 | — |
| Novartis Investigative Site | Decatur | Georgia | 30083 | — |
| Novartis Investigative Site | Idaho Falls | Idaho | 83402 | — |
| Novartis Investigative Site | Elk Grove Village | Illinois | 60007 | — |
| Novartis Investigative Site | Evanston | Illinois | 60201 | — |
| Novartis Investigative Site | Flossmoor | Illinois | 60422 | — |
| Novartis Investigative Site | Northbrook | Illinois | 60062 | — |
| Novartis Investigative Site | Anderson | Indiana | 46011 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46202-5111 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46256 | — |
| Novartis Investigative Site | Merrillville | Indiana | 46410 | — |
| Novartis Investigative Site | Valparaiso | Indiana | 46383 | — |
| Novartis Investigative Site | Des Moines | Iowa | 50314-2611 | — |
| Novartis Investigative Site | Lenexa | Kansas | 66214 | — |
| Novartis Investigative Site | Baton Rouge | Louisiana | 70809 | — |
| Novartis Investigative Site | Destrehan | Louisiana | 70047 | — |
| Novartis Investigative Site | Hammond | Louisiana | 70403 | — |
| Novartis Investigative Site | Metairie | Louisiana | 70001 | — |
| Novartis Investigative Site | Shreveport | Louisiana | 71101 | — |
| Novartis Investigative Site | Shreveport | Louisiana | 71130 | — |
| Novartis Investigative Site | Baltimore | Maryland | 21201 | — |
| Novartis Investigative Site | Bethesda | Maryland | 20814 | — |
| Novartis Investigative Site | Boston | Massachusetts | 02135 | — |
| Novartis Investigative Site | Springfield | Massachusetts | 01104 | — |
| Novartis Investigative Site | Worcester | Massachusetts | 01608 | — |
| Novartis Investigative Site | Worcester | Massachusetts | 01665 | — |
| Novartis Investigative Site | Detroit | Michigan | 48201 | — |
| Novartis Investigative Site | Grand Rapids | Michigan | 49503 | — |
| Novartis Investigative Site | Kalamazoo | Michigan | 49007 | — |
| Novartis Investigative Site | Southfield | Michigan | 48034 | — |
| Novartis Investigative Site | Bolivar | Missouri | 65613 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64111 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64132 | — |
| Novartis Investigative Site | Nixa | Missouri | 65714-7807 | — |
| Novartis Investigative Site | North Kansas City | Missouri | 64116 | — |
| Novartis Investigative Site | St Louis | Missouri | 63104 | — |
| Novartis Investigative Site | Billings | Montana | 59102 | — |
| Novartis Investigative Site | Freehold | New Jersey | 07728 | — |
| Novartis Investigative Site | Somerset | New Jersey | 08873 | — |
| Novartis Investigative Site | Teaneck | New Jersey | 07666 | — |
| Novartis Investigative Site | Toms River | New Jersey | 08755 | — |
| Novartis Investigative Site | Amherst | New York | 14226 | — |
| Novartis Investigative Site | Latham | New York | 12110 | — |
| Novartis Investigative Site | New York | New York | 10023 | — |
| Novartis Investigative Site | Patchogue | New York | 11772 | — |
| Novartis Investigative Site | Plainview | New York | 11803 | — |
| Novartis Investigative Site | Asheville | North Carolina | 28806 | — |
| Novartis Investigative Site | Burlington | North Carolina | 27215 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28204 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27401 | — |
| Novartis Investigative Site | Greenville | North Carolina | 27834 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27607 | — |
| Novartis Investigative Site | Salisbury | North Carolina | 28144 | — |
| Novartis Investigative Site | Wilmington | North Carolina | 28401 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Akron | Ohio | 44320 | — |
| Novartis Investigative Site | Bellevue | Ohio | 44811 | — |
| Novartis Investigative Site | Canton | Ohio | 44718 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45219 | — |
| Novartis Investigative Site | Columbus | Ohio | 43221 | — |
| Novartis Investigative Site | Uniontown | Ohio | 44685 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73112 | — |
| Novartis Investigative Site | Corvallis | Oregon | 97330 | — |
| Novartis Investigative Site | Eugene | Oregon | 97401 | — |
| Novartis Investigative Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Portland | Oregon | 97223 | — |
| Novartis Investigative Site | Monroeville | Pennsylvania | 15146 | — |
| Novartis Investigative Site | Rumford | Rhode Island | 02916 | — |
| Novartis Investigative Site | Beufort | South Carolina | 29902 | — |
| Novartis Investigative Site | Columbia | Tennessee | 38401 | — |
| Novartis Investigative Site | Cordova | Tennessee | 38018 | — |
| Novartis Investigative Site | Knoxville | Tennessee | 37934 | — |
| Novartis Investigative Site | Nashville | Tennessee | 37205 | — |
| Novartis Investigative Site | Austin | Texas | 78756 | — |
| Novartis Investigative Site | Colleyville | Texas | 76034 | — |
| Novartis Investigative Site | Dallas | Texas | 75204 | — |
| Novartis Investigative Site | Houston | Texas | 77025 | — |
| Novartis Investigative Site | Lubbock | Texas | 79410 | — |
| Novartis Investigative Site | Plano | Texas | 75075 | — |
| Novartis Investigative Site | Round Rock | Texas | 78681 | — |
| Novartis Investigative Site | San Antonio | Texas | 78229 | — |
| Novartis Investigative Site | San Antonio | Texas | 78258 | — |
| Novartis Investigative Site | Sherman | Texas | 75092 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84103 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Richmond | Virginia | 23226 | — |
| Novartis Investigative Site | Roanoke | Virginia | 24014 | — |
| Novartis Investigative Site | Vienna | Virginia | 22182 | — |
| Novartis Investigative Site | Kirkland | Washington | 98034 | — |
| Novartis Investigative Site | Seattle | Washington | 98122 | — |
| Novartis Investigative Site | Seattle | Washington | 98144 | — |
| Novartis Investigative Site | Morgantown | West Virginia | 26506-9260 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01216072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01216072 live on ClinicalTrials.gov.